It mentions several prescription or generic drugs that increased in prices over the years including the tuberculosis (TB) drug cycloserine, the infectious disease drug Daraprim, and the generic blood pressure medication Capto...
in the final months of his last term, Trump issued two executive orders aimed at reducing prescription drug costs: The first was to ban PBMS from taking rebates on discounted drugs purchased by seniors in Medicare; The second is an attempt to impose a "most-favouried...
The House bill also address prescription drug costs by: regulating the pharmacy benefit manager (PBM) industry; increasing transparency into PBMs and drug manufacturers through the Health Policy Commission (HPC) and the Center for Health Information and Analysis (CHIA); and by requiring pharmacists to...
inpatient hospital costs, and outpatient hospital costs have all increased dramatically since 2014. Prescription drug prices are no longer increasing at the fastest rate compared to other medical goods and services. However, they aren’t far behind inpatient hospital costs, which rose 4.1% in 2021 ...
“Right now it’s a fertile time where people are trying to do a lot of things to address rising drug prices,” she said. In addition, Sarpatwari suggested, regulators also can take steps to make sure generic versions are available when a drug’s exclusivity lapses, and promote the avail...
“Accountability and transparency are essential to developing a better understanding of rising pharmacy costs,” said Maureen Sullivan, chief strategy and innovation officer for the Blue Cross Blue Shield Association (BCBSA). “The Blue Cross Blue Shield Association developed the Alliance for...
The U.S. Food and Drug Administration (FDA) has approved the highest number of generic drugs in its history during fiscal year 2018 as a means to combat rising prescription drug costs, according to Health and Human Services Secretary Alex Azar. “The FDA is approving a record number of gene...
"Accountability and transparency are essential to developing a better understanding of rising pharmacy costs," said Maureen Sullivan, chief strategy and innovation officer for the Blue Cross Blue Shield Association (BCBSA). "The Blue Cross Blue Shield Association developed the Alliance for Health Resear...
Rising prescription drug costs continue to place a financial burden on patients and employers; however, reducing the use of high-cost, low-value drugs on formularies could lower drug spending and out-of-pocket costs for enrollees, according to a brief published by The Commonwealth Fund. The aut...
Since the year 2000, the annual percent change in prescription drug costs was moderate, due largely to brand-name drugs going off patent, which allows for substitution with generic formulations at significantly lower costs than the corresponding brand drug. But recently, both generic and brand name...